Hull Public Health 

The Deep, Hull The Guildhall, Hull King William Statue, Market Place, Hull City Hall, Hull Spurn Lightship, The Marina, Hull

 

 

Vaccinations and Immunisations


Documents

The main documents including information on vaccinations and immunisations are as follows:

JSNA
Hull JSNA Toolkit: Vaccinations and Immunisations
Hull JSNA Toolkit: Children and Young People
Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here)
Public Health Outcomes Framework Summary

Back to top


Background

There are vaccination and immunisation programmes in place for a number of diseases. Some of the programmes cover all children and young people, whereas others are for specific groups such as those aged 65+ years or 'at risk' groups. Details of the vaccination and immunisation programme in place for children and young people are given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

A number of indicators in the Public Health Outcomes Framework relate to vaccinations and immunisations. These include the majority of those given prior to the age of 5 years:

Hepatitis B vaccine
Diphtheria, tetanus and pertussis (DTP) vaccine
Inactivated Polio Vaccine (IPV)
Haemophilus influenzae type b (Hib) vaccine
Meningococcal C (MenC) vaccination
Pneumococcal conjugate vaccine (PCV)
Measles, mumps and rubella (MMR)

Other Public Health Outcomes Framework indicators related to vaccinations and immunisations include:

Human papillomavirus (HPV) types 16 and 18 vaccine given to girls aged 12-13 years
Influenza vaccination and the pneumococcal polysaccharide vaccine (PPV) given to those aged 65+ years
Influenza vaccination given to 'at risk' groups

Further analysis is given in the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


At Risk Groups

Information on influenza vaccination uptake among people on the four disease registers are given within Hull JSNA Toolkit: Vaccinations and Immunisations as well as the relevent disesase-specific Hull JSNA Toolkit reports. The diseases are coronary heart disease (CHD), stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease (COPD). Further information is available on the diseases within Cardiovascular Disease, Diabetes and Chronic Obstructive Pulmonary Disease.

Influenza vaccination among those 'at risk' is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Benchmarking

Comparator Areas gives details of the comparator areas which are similar to Hull and have been used for benchmarking within Hull JSNA Toolkit: Vaccinations and Immunisations and other local reports. Various factors such as population, ethnicity, deprivation, housing stock, etc are examined in relation to the characteristics of Hull in the Comparator Areas and Hull JSNA Toolkit: Vaccinations and Immunisations. These comparator areas are also used within the local analysis of the Public Health Outcomes Framework indicators, and the list can be seen within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here).

The general practices in Hull differ with regard to their registered population in terms of deprivation and age of patients. Whilst general practices can be compared, it is better and easier to try to compare like-with-like. As a result, the general practices in Hull have been grouped according to the average deprivation score of their patients and the average age of their patients. The General Practice Comparator Groupings document provides further details.

Back to top


Black and Minority Ethnic (BME) groups

The child vaccination rates have been compared between British White and BME groups within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

Back to top


Children and Young People

Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People give the schedule of vaccinations for children and young people. The uptake rates are also given, where data is available information is presented at practice level and at ward level. Information is included on the JSNA Hull Atlas.

A number of indicators within Public Health Outcomes Framework relate to vaccinations and immunisations of children and young people and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here), Public Health Outcomes Framework Children and Young People Report and Public Health Outcomes Framework Summary. The indicators include:

Hepatitis B vaccine
Diphtheria, tetanus and pertussis (DTP) vaccine
Inactivated Polio Vaccine (IPV)
Haemophilus influenzae type b (Hib) vaccine
Meningococcal C (MenC) vaccination
Pneumococcal conjugate vaccine (PCV)
Measles, mumps and rubella (MMR)
Human papillomavirus (HPV) types 16 and 18 vaccine given to girls aged 12-13 years

Back to top


Chronic Obstructive Pulmonary Disease (COPD)

Information on influenza vaccination uptake among those on the chronic obstructive pulmonary disease register is also given within Hull JSNA Toolkit: Chronic Obstructive Pulmonary Disease. For more information on chronic obstructive pulmonary disease, see Chronic Obstructive Pulmonary Disease.

Influenza vaccination among those 'at risk' (which includes those on the coronary heart disease, stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease registers) is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Communicable Diseases

Information on vaccinations and immunisations for children and young people, among those 'at risk' and those aged 65+ years are given in Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People. Where information is available, uptake rates are presented at practice level and/or ward level.

The majority of these indicators for vaccinations and immunisations are included within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Coronary Heart Disease (CHD)

Information on influenza vaccination uptake among those on the coronary heart disease register is given within Hull JSNA Toolkit: Coronary Heart Disease. For more information on coronary heart disease, see Cardiovascular Disease.

Influenza vaccination among those 'at risk' (which includes those on the coronary heart disease, stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease registers) is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Diabetes

Information on influenza vaccination uptake among those on the diabetes register is given within Hull JSNA Toolkit: Diabetes. For more information on diabetes, see Diabetes.

Influenza vaccination among those 'at risk' (which includes those on the coronary heart disease, stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease registers) is an indicator within Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Diphtheria

Information relating to the diphtheria, tetanus and pertussis (DTP) vaccination is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of DTP is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Diphtheria, Tetanus and Pertussis (Whooping Cough) (DTP)

Information relating to the diphtheria, tetanus and pertussis (DTP) vaccination is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of DTP is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


General Practices

The general practices in Hull differ with regard to their registered population in terms of deprivation and age of patients. Whilst general practices can be compared, it is better and easier to try to compare like-with-like. As a result, the general practices in Hull have been grouped according to the average deprivation score of their patients and the average age of their patients. The General Practice Comparator Groupings document provides further details.

Information at practice level in relation to childhood vaccinations and immunisations is presented within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

Back to top


Haemophilus Influenzae Type B (Hib)

Information relating to the haemophilus influenzae type b (Hib) vaccine is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the haemophilus influenzae type b vaccine among one and two year olds and uptake of the haemophilus influenzae type b and meningococcal C vaccine booster among two and five year olds are indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. Uptake among one year olds and uptake of the booster for two year olds are also given at ward level in the JSNA Hull Atlas.

Back to top


Hepatitis B

The uptake of the hepatitis B vaccine among one and two year olds are indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Human Papillomavirus (HPV)

Uptake rates among girls for the human papillomavirus (HPV) types 16 and 18 vaccine is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People. Information relating to risk factors for cervical cancer and uptake rates for cervical cancer screening are also given within Hull JSNA Toolkit: All Cancers.

Vaccination uptake rates for HPV among girls aged 12-13 years is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Inactivated Polio Vaccine (IPV)

Information relating to the Inactivated Polio Vaccine (IPV) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the Inactivated Polio Vaccine is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This information is also given at ward level for one year olds in the JSNA Hull Atlas.

Back to top


Influenza

Influenza vaccination uptake information relating to people aged 65+ years and those 'at risk' is given in Hull JSNA Toolkit: Vaccinations and Immunisations as well as the relevant disease-specific Hull JSNA Toolkit reports. Information on the 'at risk' groups include those people on four disease registers: coronary heart disease (CHD), stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease (COPD). Further information is available on the diseases within Cardiovascular Disease, Diabetes and Chronic Obstructive Pulmonary Disease.

Uptake of influenza vaccine among those aged 65+ years and 'at risk' groups are indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Measles

The incidence of measles is given within Hull JSNA Toolkit: Children and Young People. Information relating to the Measles, Mumps and Rubella (MMR) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of MMR is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Measles, Mumps and Rubella (MMR)

Information relating to the Measles, Mumps and Rubella (MMR) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of MMR is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

The incidence of measles is given within Hull JSNA Toolkit: Children and Young People.

Back to top


Meningococcal C (MenC)

Information relating to the meningococcal C vaccination is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the meningococcal C vaccination among one year olds and haemophilus influenzae type b and meningococcal C booster vaccinations among two year olds are both indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This information is also given at ward level in the JSNA Hull Atlas.

Back to top


Mumps

Information relating to the Measles, Mumps and Rubella (MMR) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of MMR is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Older People

Influenza vaccination uptake information relating to people aged 65+ years is given in Hull JSNA Toolkit: Vaccinations and Immunisations.

Uptake of pneumococcal polysaccharide vaccine (PPV) and influenza vaccine among those aged 65+ years are both indicators within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Pertussis / Whooping Cough

The incidence of pertussis (whooping cough) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People. Information relating to the diphtheria, tetanus and pertussis (DTP) vaccination is also given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of DTP is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Pneumococcal Conjugate Vaccine (PCV)

Information relating to the pneumococcal conjugate vaccine is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the pneumococcal conjugate vaccine is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Pneumococcal Polysaccharide Vaccine (PPV)

Information relating to the pneumococcal polysaccharide vaccine is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the pneumococcal polysaccharide vaccine is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Information on other Vaccinations and Immunisations is also available.

Back to top


Polio / Inactivated Polio Vaccine (IPV)

Information relating to the Inactivated Polio Vaccine (IPV) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of the Inactivated Polio Vaccine is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This information is also given at ward level among one year olds in the JSNA Hull Atlas.

Back to top


Pregnancy

There are some indicators within the Public Health Outcomes Framework relating to screening of pregnant women against disease, and based on these results vaccination and immunisation of the mother or babies may be required, although data are currently unavailable for further analysis.

Back to top


Public Health Outcomes Framework

A number of indicators within the Public Health Outcomes Framework relate to vaccinations and immunisations of children, young people and older people. Further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. These include the majority of those given prior to the age of 5 years:

Hepatitis B vaccine
Diphtheria, tetanus and pertussis (DTP) vaccine
Inactivated Polio Vaccine (IPV)
Haemophilus influenzae type b (Hib) vaccine
Meningococcal C (MenC) vaccination
Pneumococcal conjugate vaccine (PCV)
Measles, mumps and rubella (MMR)

Other Public Health Outcomes Framework indicators related to vaccinations and immunisations include:

Human papillomavirus (HPV) types 16 and 18 vaccine given to girls aged 12-13 years
Influenza vaccination and the pneumococcal polysaccharide vaccine (PPV) given to those aged 65+ years
Influenza vaccination given to 'at risk' groups

Back to top


Rubella

Information relating to the Measles, Mumps and Rubella (MMR) is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of MMR is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Screening

For some vaccinations particularly those administrated in antenatal care are based on screening or assessing level of risk. For example, not all women will be eligible for sickle cell screening. For more information, see Screening.

Another link between vaccinations and immunisations with screening occurs for human papillomavirus (HPV) types 16 and 18 with a vaccination programme in place for HPV and a screening programme in place for cervical cancer. The majority of cases of cervical cancer are caused by the human papillomavirus, and vaccination against types 16 and 18 will in future reduce the numbers of cervical cancer substantially.

Back to top


Stroke

Information on influenza vaccination uptake among those on the stroke and transient ischaemic attack register is also given within Hull JSNA Toolkit: Stroke. For more information on stroke, see Cardiovascular Disease.

Influenza vaccination among those 'at risk' (which includes those on the coronary heart disease, stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease registers) is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top


Tetanus

Information relating to the diphtheria, tetanus and pertussis (DTP) vaccination is given within Hull JSNA Toolkit: Vaccinations and Immunisations and Hull JSNA Toolkit: Children and Young People.

The uptake of DTP is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary. This is also given at ward level in the JSNA Hull Atlas.

Back to top


Transient Ischaemic Attack

Information on influenza vaccination uptake among those on the stroke and transient ischaemic attack register is also given within Hull JSNA Toolkit: Stroke. For more information on transient ischaemic attack, see Cardiovascular Disease.

Influenza vaccination among those 'at risk' (which includes those on the coronary heart disease, stroke and transient ischaemic attack, diabetes and chronic obstructive pulmonary disease registers) is an indicator within the Public Health Outcomes Framework and further analysis is given within the Public Health Outcomes Framework Main Report (to open this report on a particular PHOF indicator, click here) and Public Health Outcomes Framework Summary.

Back to top